Delcath (DCTH) 2026 Earnings Outlook: What Investors Need
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Why Choose An Index Fund focuses on simplicity, broad exposure, and cost efficiency as strong reasons for a long-term approach.
21,836 articlesBiotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Trump Media posted a $405.9 million quarterly loss in Q1 2026, largely tied to unrealized cryptocurrency holdings, ev...
Analysts say the global economy is entering the largest capex cycle on record, fueled by energy transition and surgin...
Dream Finders' unsolicited cash offer values Beazer at about $704 million, sparking a public contest as U.S. homebuil...
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
Multibank Group’s Crypto mb.io has unveiled an institutional gold tokenization initiative in West Africa, pairing Dub...
New York City honors Jack Kirby with a street-name dedication on a Lower East Side block, recognizing the immigrant a...
Cardano is sparking renewed trader interest as ADA price predictions point to a potential rally. Analysts cite chart ...
Solesence kicked off 2026 with a solid Q1 showing across core segments. This deep dive breaks down the numbers, what ...
Tesla stock trades near the mid-$400s as margins and cash flow improve, but the tesla price prediction: stock outlook...
NVIDIA breached a $5.5 trillion market cap, marking a historic leap for a chipmaker tied to AI. The move highlights t...